Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.77M Sell
188,482
-30,304
-14% -$1.4M 0.01% 588
2026
Q1
$10.7M Buy
+218,786
New +$10.2M 0.01% 488
2025
Q3
$7.94M Buy
+176,304
New +$7.74M 0.04% 310

Other funds holding EXC

CIBC Bancorp USA's EXC Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Exelon (EXC) stake by 14% in Q2 2026, selling an estimated $1.4M and leaving 188,482 shares worth $8.77M. The position accounts for 0.01% of the portfolio, ranked #588.

CIBC Bancorp USA first reported a position in EXC in Q3 2025 and has held it in 3 quarters since. The position peaked at $10.7M in Q1 2026. 1,292 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • CIBC Bancorp USA held 188,482 shares of Exelon worth $8.77M as of Q2 2026.
  • CIBC Bancorp USA sold 30,304 Exelon shares in Q2 2026, an estimated $1.4M.
  • Exelon made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #588 holding.
  • CIBC Bancorp USA first reported a position in Exelon in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Exelon position peaked at $10.7M in Q1 2026.
  • 1,292 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.